Medical is one of the broader sectors among the 16 Zacks sectors that are expected to report earnings growth in the first quarter.
- Zacks•5 days ago
Edward Lifesciences Corp. (EW) is scheduled to report first-quarter 2017 earnings results after market close on Apr 25.
- PR Newswire•6 days ago
IRVINE, Calif., April 19, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, has received FDA clearance for its HemoSphere advanced monitoring platform. This technology provides clinicians with exceptional clarity on a patient's hemodynamics, or the factors that manage blood flow, to help them make proactive, timely clinical decisions. It's also a scalable platform that can be tailored to meet the needs of each patient and clinician.
EW: Summary for Edwards Lifesciences Corporatio - Yahoo Finance
Edwards Lifesciences Corporation (EW)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
|Bid||96.96 x 200|
|Ask||98.15 x 100|
|Day's range||97.63 - 99.43|
|52-week range||81.12 - 121.75|
Trade prices are not sourced from all markets
|PE ratio (TTM)||37.53|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|